These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37521244)

  • 1. Lower low density lipoprotein cholesterol associates to higher mortality in non-diabetic heart failure patients.
    Gouveia R; Madureira S; Elias C; Neves A; Soares PR; Soares-Carreira M; Pereira J; Ribeiro A; Amorim M; Almeida J; Araújo JP; Lourenco P
    Int J Cardiol Cardiovasc Risk Prev; 2023 Sep; 18():200197. PubMed ID: 37521244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholesterol paradox may be attenuated in heart failure patients with diabetes.
    Cunha FM; Pereira J; Ribeiro A; Silva S; Araújo JP; Leite-Moreira A; Bettencourt P; Lourenço P
    Minerva Med; 2019 Dec; 110(6):507-514. PubMed ID: 31638359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the blood pressure paradox observed in all heart failure patients?
    Cunha FM; Lourenço P; Couto M; Tavares P; Silva S; Guimarães JT; Bettencourt P
    Biomed Res Int; 2013; 2013():350289. PubMed ID: 24371821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of uric acid in acute heart failure according to coexistence of diabetes mellitus.
    Cidade-Rodrigues C; Cunha FM; Elias C; Oliveira D; Bettencourt P; Lourenço P
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3377-3383. PubMed ID: 34625362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients.
    Yao Y; Liu J; Wang B; Zhou Z; Lu X; Huang Z; Deng J; Yang Y; Tan N; Chen S; Chen J; Liu Y
    Front Cardiovasc Med; 2021; 8():817442. PubMed ID: 35097030
    [No Abstract]   [Full Text] [Related]  

  • 6. Malnutrition affects cholesterol paradox in coronary artery disease: a 41,229 Chinese cohort study.
    Wang B; Liu J; Chen S; Ying M; Chen G; Liu L; Lun Z; Li H; Huang H; Li Q; Yu Y; Lin M; Wei W; Huang Z; Yang Y; Chen J; Tan N; Liu Y
    Lipids Health Dis; 2021 Apr; 20(1):36. PubMed ID: 33874960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population.
    Séguro F; Bongard V; Bérard E; Taraszkiewicz D; Ruidavets JB; Ferrières J
    Arch Cardiovasc Dis; 2015 Oct; 108(10):511-8. PubMed ID: 26073227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of lipoprotein(a) in patients undergoing percutaneous coronary intervention modified by low density lipoprotein cholesterol.
    Xu N; Yuan D; Yao Y; Jiang L; Xu J; Tang X; Song Y; Gao L; Chen J; Song L; Zhao X; Chen J; Yang Y; Xu B; Gao R; Yuan J
    Clin Chim Acta; 2023 Feb; 540():117217. PubMed ID: 36610466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Friedewald's calculated low-density lipoprotein cholesterol levels with direct low-density lipoprotein cholesterol levels in a tertiary care hospital.
    Nanda SK; Bharathy M; Dinakaran A; Ray L; Ravichandran K
    Int J Appl Basic Med Res; 2017; 7(1):57-62. PubMed ID: 28251110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus.
    Wang R; Gerstein HC; Van Spall HGC; Lip GYH; Olier I; Ortega-Martorell S; Thabane L; Ye Z; Li G
    Eur Heart J Qual Care Clin Outcomes; 2023 Aug; 9(5):537-545. PubMed ID: 37226578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of magnesium in acute heart failure is different according to the presence of diabetes mellitus.
    Cidade-Rodrigues C; Cunha FM; Elias C; Carreira M; Barroso I; Bettencourt P; Lourenço P
    Porto Biomed J; 2022; 7(6):e197. PubMed ID: 37152077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.
    Simons L; Tonkon M; Masana L; Maccubbin D; Shah A; Lee M; Gumbiner B
    Curr Med Res Opin; 2004 Sep; 20(9):1437-45. PubMed ID: 15383192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the precision of the Friedewald's formula for the calculation of low density lipoprotein cholesterol concentration in serum].
    Chotkowska E; Kurjata P; Kupść W
    Pol Merkur Lekarski; 2001 Oct; 11(64):348-51. PubMed ID: 11770317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
    Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
    Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between baseline LDL-C and prognosis among patients with coronary artery disease and advanced kidney disease.
    Wang B; Chen S; Liu J; Liang Y; Meng L; Yan X; Huang H; Chen G; Huang Z; Xu D; Li M; Liang J; Liu S; Chen J; Liu Y; Tan N
    BMC Nephrol; 2021 May; 22(1):168. PubMed ID: 33957880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.